Bartkowiak et al. demonstrated recently that 4-1BB agonist antibodies trigger hepatitis via activation of 4-1BB on liver myeloid cells, which leads to CD8 T cells infiltration, tissue damage and transaminase elevation [32]. Here, TNFRSF9 is linked to hepatitis A virus infection.